Pharmaceutical Processing World

  • Home
  • Regulatory
    • Recalls
  • Pharmaceutical Processing
  • Facility
  • Supply Chain
  • Equipment and Materials
  • Contract Manufacturing
  • R&D 100 Awards

Entegris opens Life Sciences Technology Center in Massachusetts

By Sean Whooley | May 24, 2022

Entegris logoEntegris (Nasdaq:ENTG) announced today that it opened a new Life Sciences Technology Center in Billerica, Massachusetts.

The new facility was built to offer life sciences customers the opportunity to leverage Entegris’ cold-chain supply expertise to optimize processes, reduce costs and increase speed to market, according to a news release.

Entegris’ tools and technologies will be brought together at the laboratory space, and customers can test equipment for freeze and thaw processes to determine which products best fit their needs.

The company said it is now offering Aramus-shaped 2D single-use bags with custom shapes, sizes and assembly configurations for customers’ space and function requirements as part of its manufacturing challenges solutions. They have been designed to be resistant to extreme cold temperatures and to withstand gamma sterilization, making them an option for freezing, transporting, storing and thawing drug substances like COVID-19 vaccines, cell therapies and gene therapies.

“Maintaining product quality, process robustness, reliability and safety is critical for any pharmaceutical product, but novel treatments such as mRNA, gene and cell therapies often require a more intensive approach to their preparation, storage and shipping,” Entegris VP of Life Sciences John Lynch said in the news release. “Building on the success of our Aramus bag assembles and support in COVID-19 vaccine delivery, we have opened the Entegris Life Sciences Technology Center as part of our commitment to enable biopharmaceutical companies to have the technologies and processes in place to provide life-sustaining and life-improving innovations for people around the world, now and in the future.”

Tell Us What You Think! Cancel reply

Related Articles Read More >

Pfizer logo
Pfizer seeks to comply with voluntary Net-Zero Standard by 2040
Cambridge Pharma launches with UK plant in Cambridge Research Park
sustainability
How pharma can optimize for right-the-first-time drug manufacturing and sustainability
World Changing Ideas
Fast Company 2022 World-Changing Ideas Awards highlight multiple pharma innovations

DeviceTalks Tuesdays

DeviceTalks Tuesdays

MEDTECH 100 INDEX

Medtech 100 logo
Market Summary > Current Price
The MedTech 100 is a financial index calculated using the BIG100 companies covered in Medical Design and Outsourcing.

Need Pharmaceutical Processing news in a minute?

We Deliver!
Pharmaceutical Processing Enewsletters get you caught up on all the mission critical news you need. Sign up today.
Enews Signup
Pharmaceutical Processing World
  • Subscribe to Our Free E-Newsletter
  • Contact Us
  • About Us
  • Advertise With Us
  • R&D World
  • Drug Delivery Business News
  • Drug Discovery & Development
  • DeviceTalks
  • MassDevice
  • Medical Design & Outsourcing
  • MEDICAL TUBING + EXTRUSION
  • Medical Design Sourcing
  • Medtech100 Index

Copyright © 2022 WTWH Media LLC. All Rights Reserved. The material on this site may not be reproduced, distributed, transmitted, cached or otherwise used, except with the prior written permission of WTWH Media
Privacy Policy | Advertising | About Us

Search Pharmaceutical Processing World

  • Home
  • Regulatory
    • Recalls
  • Pharmaceutical Processing
  • Facility
  • Supply Chain
  • Equipment and Materials
  • Contract Manufacturing
  • R&D 100 Awards